Abstracts (HTML) List of Authors

Larghero, P

The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) ALL

Law, E

Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia

Lehnert, M

Application of mediator probe PCR chemistry in multiplex target assays for monitoring MRD of high-risk neuroblastoma

Lenk, L

A meningeal preleukemic niche promotes the homing of B-cell Precursor Acute Lymphoblastic Leukaemia cells to the CNS
Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)

Lesch, MJ

Identification and isolation of homogenous AML derived extracellular vesicles for MRD detection in pediatric AML

Li, Q

Mebendazole inhibits growth of hepatoblastoma cells by cell cycle arrest

Looi-Somoye, R

Drug repositioning for MLL-rearranged B-cell acute lymphoblastic leukaemia

Lopes, B

Unravelling the recombinome of IKZF1 deletions in B-ALL

Loxha, L

SOD2 Promotes Acute Leukemia Adaptation to Amino Acid Starvation Through the N-Degron Pathway

Ludwig, R

Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse

Lühmann, JL

IKZF1plus under investigation: Optical Genome Mapping to detect additional alterations
The extended potential of optical genome mapping (OGM) in pediatric AML compared to classical cytogenetics

Lunec, J

Ex vivo and in vivo complex drug combination analysis for improved efficacy and specificity in high-risk childhood acute lymphoblastic leukaemia

Lupas, AN

De novo design of cytokines, antikines, and novokines
De novo design of growth factor inhibiting proteins

Luque-Martin, R

Understanding the FLT3-ITD maintenance and relapse pathways by RNAi screens